Pfizer’s new obesity bet, Metsera, releases drug data
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A model of this text first appeared in CNBC’s Healthy Returns publication, which brings the newest health-care information straight to…
International News Central
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A model of this text first appeared in CNBC’s Healthy Returns publication, which brings the newest health-care information straight to…
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer stated on Monday it might purchase weight-loss drug developer Metsera in a deal valued up to $7.3 billion, together…